Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Xanthohumol

Xanthohumol is one of the principal flavonoids isolated from hops, the inhibitor of diacylglycerol acetyltransferase (DGAT), COX-1 and COX-2, and shows anti-cancer and anti-angiogenic activities. Xanthohumol also has antiviral activity against bovine viral diarrhea virus (BVDV), rhinovirus, HSV-1, HSV-2 and cytomegalovirus (CMV) .

Product Specifications

CAS Number

6754-58-1

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Acyltransferase; Apoptosis; CMV; COX; HSV; Influenza Virus

Type

Natural Products

Related Pathways

Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease

Applications

Cancer-Kinase/protease

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/Xanthohumol.html

Purity

99.97

Solubility

DMSO : 83.33 mg/mL (ultrasonic)

Smiles

O=C(C1=C(OC)C=C(O)C(C/C=C(C)\C)=C1O)/C=C/C2=CC=C(O)C=C2

Molecular Formula

C21H22O5

Molecular Weight

354.40

Precautions

H302, H315, H319, H335

References & Citations

[1]Luzak B, et al. Xanthohumol from hop cones (Humulus lupulus L.) prevents ADP-induced platelet reactivity. Arch Physiol Biochem. 2016 Nov 18:1-7|[2]Arnaiz-Cot JJ, et al. Xanthohumol modulates calcium signaling in rat ventricular myocytes: Possible Antiarrhythmic properties. J Pharmacol Exp Ther. 2016 Nov 4. pii: jpet.116.236588|[3]Gallo C, et al. Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation. Oncotarget. 2016 Aug 1|[4]Chen PH, et al. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death. Neuropharmacology. 2016 Nov;110 (Pt A) :362-75.|[5]Buckwold VE, et al. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res. 2004 Jan;61 (1) :57-62.|[6]Inokoshi J, et al. Expression of two human acyl-CoA:diacylglycerol acyltransferase isozymes in yeast and selectivity of microbial inhibitors toward the isozymes. J Antibiot (Tokyo) . 2009;62 (1) :51-54.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Natural Products

Clinical Information

Phase 2

Isoform

COX-1; COX-2; HSV-1; HSV-2

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/1619), CF405S conjugate, 0.1mg/mL
BNC041619-100 1x 100 µL

CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/1619), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CSN1 (GPS1) (NM_212492) Human Over-expression Lysate
LY403953 100 µg

CSN1 (GPS1) (NM_212492) Human Over-expression Lysate

Sign In for Pricing
View Details
Cytokeratin 8 (H1), Biotin conjugate, 0.1mg/mL
BNCB0334-100 1x 100 µL

Cytokeratin 8 (H1), Biotin conjugate, 0.1mg/mL

Sign In for Pricing
View Details
FAIM1 (FAIM) (NM_001033032) Human Over-expression Lysate
LC422347 20 µg

FAIM1 (FAIM) (NM_001033032) Human Over-expression Lysate

Sign In for Pricing
View Details
EWSR1 Polyclonal Antibody
E-AB-18995-01 20 µL

EWSR1 Polyclonal Antibody

Sign In for Pricing
View Details
EWSR1 Polyclonal Antibody
E-AB-18995-02 60 µL

EWSR1 Polyclonal Antibody

Sign In for Pricing
View Details